Livzon Pharmaceutical Group Overview
- Founded
- 1985

- Status
- Public
- Employees
- 8,020

- Stock Symbol
- 000513

- Investments
- 8
- Share Price
- $5.82
- (As of Friday Closing)
Livzon Pharmaceutical Group General Information
Description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises of western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drugs address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system and other conditions. The Company distributes its products within domestic market and to overseas markets. The company operates in a single reportable segment that is pharmaceutical manufacturing.
Contact Information
- No.132, Guihua Road North
- Gongbei, Zhuhai
- Guangdong, 519020
- China
Livzon Pharmaceutical Group Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$5.82 | $5.82 | $4.72 - $8.97 | $4.77B | 939M | 7.45M | $0.26 |
Livzon Pharmaceutical Group Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 5,162,965 | 3,093,834 | 1,601,241 | 4,243,782 |
Revenue | 1,428,304 | 1,358,203 | 1,339,423 | 1,262,360 |
EBITDA | 325,317 | 273,962 | 236,025 | 889,184 |
Net Income | 240,242 | 188,559 | 163,587 | 655,330 |
Total Assets | 2,830,178 | 2,569,241 | 2,534,867 | 2,435,057 |
Total Debt | 215,467 | 194,495 | 218,215 | 168 |
Livzon Pharmaceutical Group Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
YuCai Peng Ph.D | Vice President, Research & Technical Development |
Livzon Pharmaceutical Group Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLivzon Pharmaceutical Group Investments (8)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 0000000000 | 01-Mar-2021 | 00000 00000 00 | 0000 | Drug Discovery | |
00000000 000000000 | 05-Feb-2021 | 00000 00000 00 | Drug Discovery | ||
0000 0000000000 | 27-May-2020 | 00000 00000 00 | 0000 | Drug Discovery | |
0000 0000000000 | 17-Jan-2020 | 00000 00000 00 | 000.00 | Drug Discovery | |
Elicio Therapeutics | 02-Oct-2019 | Later Stage VC | 000.00 | Drug Discovery |
Livzon Pharmaceutical Group Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
000000 00000000 | Drug Discovery | Zhuhai, China | 0000 |
Livzon Pharmaceutical Group Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000 00000000000 | 16-Apr-2014 | 00000 00000 00 | 0000 | Completed |
|